These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33274240)
61. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
62. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
63. Determination of a CD4 Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682 [TBL] [Abstract][Full Text] [Related]
64. The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells. Peng J; Yu Z; Xue L; Wang J; Li J; Liu D; Yang Q; Lin Y Mol Med Rep; 2018 Apr; 17(4):5860-5868. PubMed ID: 29436663 [TBL] [Abstract][Full Text] [Related]
65. Diminished levels of regulatory T cell subsets (CD8+Foxp3, CD4+Foxp3 and CD4+CD39+Foxp3) but increased Foxp3 expression in adipose tissue from overweight subjects. Núñez Ruiz A; Cortés-Garcia JD; Cortez-Espinosa N; Herrera-Rojas PI; Ruíz-Rodríguez VM; Salgado-Bustamante M; García-Hernández MH; Reynaga-Hernández E; Martínez-Jimenez Vdel C; Portales-Pérez DP Nutrition; 2016 Sep; 32(9):943-54. PubMed ID: 27160497 [TBL] [Abstract][Full Text] [Related]
66. HLA class Ia and Ib molecules and FOXP3+ TILs in relation to the prognosis of malignant melanoma patients. Melsted WN; Johansen LL; Lock-Andersen J; Behrendt N; Eriksen JO; Bzorek M; Scheike T; Hviid TVF Clin Immunol; 2017 Oct; 183():191-197. PubMed ID: 28882620 [TBL] [Abstract][Full Text] [Related]
67. The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients. Sthoeger ZM; Sharabi A; Dayan M; Zinger H; Asher I; Sela U; Mozes E Hum Immunol; 2009 Mar; 70(3):139-45. PubMed ID: 19280712 [TBL] [Abstract][Full Text] [Related]
68. The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells. Messina N; Fulford T; O'Reilly L; Loh WX; Motyer JM; Ellis D; McLean C; Naeem H; Lin A; Gugasyan R; Slattery RM; Grumont RJ; Gerondakis S J Autoimmun; 2016 Jun; 70():52-62. PubMed ID: 27068879 [TBL] [Abstract][Full Text] [Related]
69. The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment. Zidlik V; Brychtova S; Uvirova M; Ziak D; Dvorackova J Int J Mol Sci; 2015 Apr; 16(4):7876-89. PubMed ID: 25913374 [TBL] [Abstract][Full Text] [Related]
70. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination. Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789 [TBL] [Abstract][Full Text] [Related]
71. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Gupta S; Joshi K; Wig JD; Arora SK Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Bonzheim I; Geissinger E; Tinguely M; Roth S; Grieb T; Reimer P; Wilhelm M; Rosenwald A; Müller-Hermelink HK; Rüdiger T Am J Clin Pathol; 2008 Oct; 130(4):613-9. PubMed ID: 18794055 [TBL] [Abstract][Full Text] [Related]
73. FOXP3 expression and nodal metastasis of breast cancer. Gökmen-Polar Y; Thorat MA; Sojitra P; Saxena R; Badve S Cell Oncol (Dordr); 2013 Oct; 36(5):405-9. PubMed ID: 23996727 [TBL] [Abstract][Full Text] [Related]
74. Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. Beyer M; Classen S; Endl E; Kochanek M; Weihrauch MR; Debey-Pascher S; Knolle PA; Schultze JL Clin Dev Immunol; 2011; 2011():734036. PubMed ID: 21904560 [TBL] [Abstract][Full Text] [Related]
75. Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability. Do JS; Zwick D; Kenyon JD; Zhong F; Askew D; Huang AY; Van't Hof W; Finney M; Laughlin MJ Sci Rep; 2021 May; 11(1):10676. PubMed ID: 34021231 [TBL] [Abstract][Full Text] [Related]
76. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795 [TBL] [Abstract][Full Text] [Related]
77. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Miyao T; Floess S; Setoguchi R; Luche H; Fehling HJ; Waldmann H; Huehn J; Hori S Immunity; 2012 Feb; 36(2):262-75. PubMed ID: 22326580 [TBL] [Abstract][Full Text] [Related]
79. Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells. Martin-Orozco N; Li Y; Wang Y; Liu S; Hwu P; Liu YJ; Dong C; Radvanyi L Cancer Res; 2010 Dec; 70(23):9581-90. PubMed ID: 21098714 [TBL] [Abstract][Full Text] [Related]
80. The CD4(+)CD8(+) and CD4(+) subsets of FOXP3(+) thymocytes differ in their response to growth factor deprivation or stimulation. Lehtoviita A; Rossi LH; Kekäläinen E; Sairanen H; Arstila TP Scand J Immunol; 2009 Oct; 70(4):377-83. PubMed ID: 19751272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]